Peter N. Laivins
Director/Board Member at GENEXINE, INC.
Peter N. Laivins active positions
Companies | Position | Start | End |
---|---|---|---|
GENEXINE, INC. | Director/Board Member | - | - |
Independent Dir/Board Member | - | - |
Career history of Peter N. Laivins
Former positions of Peter N. Laivins
Companies | Position | Start | End |
---|---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2011-09-30 | 2017-03-31 |
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Sales & Marketing | - | 2009-12-31 |
Training of Peter N. Laivins
McGill University | Masters Business Admin |
Statistics
International
United States | 3 |
Canada | 2 |
South Korea | 2 |
Operational
Sales & Marketing | 1 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectoral
Health Technology | 3 |
Distribution Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
GENEXINE, INC. | Health Technology |
Private companies | 2 |
---|---|
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Peter N. Laivins
- Experience